Todas as matérias desta categoria, das mais recentes às mais antigas.
Agomab (NASDAQ:AGMB) reported topline results from the STENOVA open-label extension study of ontunisertib in patients with fibrostenosing Crohn’s disease, with 49 patients completing the 48-week extension period.
Origin Agritech (NASDAQ:SEED) entered into an agreement to sell its principal corn seed production subsidiary stake as part of a transaction involving Xinjiang Originbo.
Anastasia Amoroso, Chief Investment Strategist of Partners Group, joins Bloomberg's Vonnie Quinn on "Bloomberg Brief" to discuss the US Challenger September job cuts data along with the rise of yields.
Shattuck Labs (NASDAQ:STTK) announced plans to evaluate SL-325 in a Phase 2 clinical trial for patients with moderate to severe hidradenitis suppurativa (HS), expanding the program beyond its existing inflammatory bowel disease development.
CenterPoint Energy (NYSE:CNP) completed the sale of its Ohio natural gas distribution business, Vectren Energy Delivery of Ohio, to National Fuel Gas Company for $2.62 billion.
Nebius (NASDAQ:NBIS) announced the acquisition of Inferize, an inference optimization company whose technology helps reduce the time required to launch and scale large artificial intelligence models.
Commerce Bank announced the completion of its acquisition of Nolan & Associates, a St. Louis-based investment banking firm focused on serving middle-market companies nationwide.
Kelsey Berro, fixed income portfolio manager at JPMorgan Asset Management, discusses recent changes in the bond market selloff, saying it now feels "very technically-driven, very momentum-driven." Berro says on "Bloomberg Surveillance" that she expects investors to refocus soon on the fundamentals and valuations of the market.
A move higher in oil is putting even more pressure on bonds, with yields hitting new milestones in a number of markets including the UK and the US. The UK's long-term borrowing costs hit 6% for the first time in almost three decades whilst the 10-year Treasury note climbed to the highest since 2002. It comes as government debt has been flailing around the world as uncertainty tied to the war in the Middle East ripples through the global economy, pushing investors to bet central banks will further raise interest rates. But bond veteran Jim Bianco, President and Founder of Bianco Research, is bullish on US sovereign debt on the basis of value generation. He discusses the reasoning behind his position with Caroline Hepker and Nathan Hager.
Eli Lilly (NYSE:LLY) reported post-hoc analyses from the Phase 3 ATTAIN-1 trial showing Foundayo was associated with lower modeled 10-year risks of type 2 diabetes and cardiovascular disease in adults with obesity or overweight.
Accenture (NYSE:ACN) reported fiscal fourth-quarter revenue of $18.7 billion and full-year fiscal 2026 revenue of $74.2 billion, with full-year diluted earnings per share increasing 12% to $13.56.
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, explains why he expects volatility in stocks in the fourth quarter and frames rising bond yields as "a new normal."
